• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Organisation › Details

Proteome Sciences (Group)

With its HQ in Cobham, UK and laboratory facilities in London and Frankfurt, Proteome Sciences is a global leader in applied proteomics offering high sensitivity, proprietary technologies and workflows in cell signalling pathways (SysQuant®, TMTcalibrator™) and in protein biomarker discovery, validation and assay development. PS Biomarker Services® provides proteomics outsourcing services and proprietary biomarker assays from its ISO 9001: 2008 facility in Frankfurt, Germany to pharmaceutical, biotechnology, diagnostics companies and academia. Proteome Sciences' research has discovered a large number of novel protein biomarkers in key human diseases with a focus mainly in neurological/neurodegenerative conditions and in cancer. It has patented blood biomarkers in Alzheimer's disease, stroke, brain damage and cancers for diagnostic and treatment applications that are available for licenses. *

 

	Start	2005-07-23 existent
	Industry	proteomics
	Industry 2	TMT® (isobaric tandem mass tag) technology
	Person	Haigh, Jeremy (Proteome Sciences 201606– CEO before Amgen European Chief Operating Officer + Merck)
	Person 2	Pearce, Christopher (Proteome Sciences 201606– Non-executive Chairman before CEO)
	Region	Cobham, Surrey
	Country	United Kingdom (GB)
	Street	Downside Bridge Road Coveham House
	City	KT11 3EP Cobham, Surrey
	Tel	+44-1932-865065
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
	Currency	GBP
	Annual sales	1,882,000 (revenue, total, consolidated (2015) 2015-12-31)
	Profit	-2,718,000 (2015-12-31)
	Cash	1,808,000 (2015-12-31)
		* Document for �About Section�: Proteome Sciences plc. (5/18/16). "Press Release: Preliminary Results for the Year Ended 31st December, 2015". Cobham.
		Record changed: 2018-10-30

Advertisement

More documents for Proteome Sciences (Group)

• [1] Proteome Sciences plc. (9/14/20). "Press Release: Appointment of Chief Executive Officer"....
• [2] Thermo Fisher Scientific Inc.. (6/4/18). "Press Release: Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2018". San Diego, CA....
• [3] Proteome Sciences plc. (10/31/16). "Press Release: Placing and Subscription of 66,258,100 New Ordinary Shares at 5 Pence perShare and Notice of General Meeting"....
• [4] Proteome Sciences plc. (9/22/16). "Press Release: Study Demonstrates Mass Spectrometry Technique Dramatically Enhances Detection of Key Early Stage Alzheimer's Biomarkers. Publication: Journal of Alzheimer's disease". Cobham....
• [5] Proteome Sciences plc. (9/15/16). "Press Release: Interim Results. Proteome Sciences Today Releases Its Unaudited Interim Results for the Six Months Ended 30th June 2016"....
• [6] Proteome Sciences plc. (7/28/16). "Press Release: Trading Update and Notice of Results"....
• [7] Thermo Fisher Scientific Inc.. (6/8/16). "Press Release: Thermo Fisher Scientific Recognizes Tandem Mass Tag Grant Award Winners at ASMS 2016". San Antonio, TX....
• [8] Proteome Sciences plc. (6/1/16). "Press Release: CEO Appointment"....
• [9] Proteome Sciences plc. (5/31/16). "Press Release: Publication of Annual Report"....
• [10] Proteome Sciences plc. (5/18/16). "Press Release: CEO Appointment"....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2022. Made in Germany.